Skip to main content
. Author manuscript; available in PMC: 2011 Jan 25.
Published in final edited form as: Am J Ophthalmol. 2009 Dec 30;149(3):513–522. doi: 10.1016/j.ajo.2009.09.024

Table 4.

Allele and Genotype Frequencies for the Leu55Met PON1 Polymorphism Identified in AMD Patient and Control Populations.

Controls Cat 1 Cat 2 Cat 3 Cat 4 All AMD (Cat 2 – 4) All AMD (Cat 1 – 4)
N = 368 N = 117 N = 175 N = 105 N = 522 N = 802 N = 919

Alleles
T 486 (66.0) 161 (68.8) 212 (60.6) 125 (59.5) 647 (62.0) 984 (61.3) 1145 (62.3)
A 250 (34.0) 73 (31.2) 138 (39.4) 85 (40.5) 397 (38.0) 620 (38.7) 693 (37.7)
Significance* P = 0.474 P = 0.090 P = 0.086 P = 0.080 P = 0.030 P = 0.078
Genotypes
TT 161 (43.7) 56 (47.8) 64 (36.6) 34 (32.4) 198 (37.9) 296 (36.9) 352 (38.3)
TA 164 (44.6) 49 (41.9) 84 (48.0) 57 (54.3) 251 (48.1) 392 (48.9) 441 (48.0)
AA 43 (11.7) 12 (10.3) 27 (15.4) 14 (13.3) 73 (14.0) 114 (14.2) 126 (13.7)
Significance* P = 0.726 P = 0.215 P = 0.111 P = 0.196 P = 0.074 P = 0.179
*

Comparison with control frequencies, Fisher’s Exact (alleles) and χ2 test (genotypes).

Data expressed as the number of subjects (% of entire group).

PON1: Paraoxonase 1

AMD: age-related macular degeneration